These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2019-004901-28 A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort, Dose-Ranging Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis 2021-11-10 bad-data
Not reported 2021-001805-63 A phase 2, multicenter, double-blind, placebo-controlled, multiple-cohort study investigating the effect of EDP1815 in participants for the treatment of mild, moderate and severe atopic dermatitis 2023-03-28 due-trials
Not reported Terminated 2022-000284-48 A Long-Term Extension Trial in participants with Atopic Dermatitis who participated in previous Phase 2 and 3 EDP1815 trials 2023-04-26 due-trials
Reported results 2022-001631-82 A Phase 1/2, randomised, placebo-controlled study of EDP2939 in healthy volunteers and participants with moderate plaque psoriasis. 2023-09-06 due-trials